Medical Condition News

RSS

Study reveals the widespread impact of pandemic on long COVID patients and people with other illnesses

Long COVID patients can experience many of the same lingering negative effects on their physical, mental, and social well-being as those experienced by people who become ill with other, non-COVID illnesses, new research suggests.

1 Dec 2022

New program lowers the risk of car crashes for teenagers with ADHD

Research published in the New England Journal of Medicine has shown that a computerized program enhanced with driving simulation training with feedback lowers the risk of car crashes for teenagers with Attention Deficit Hyperactivity Disorder (ADHD).

1 Dec 2022

Study implicates gut microbiome health in Parkinson's disease

A new study published in the journal Nature Communications discusses the links between this condition that affects the brain and changes in the gut microbiome that may predate brain changes.

1 Dec 2022

Very low-calorie and vegan diets improve glycemic control in type 2 diabetes

Very low-calorie diets and vegan diets improve weight loss and anthropometric markers in type 2 diabetes patients.

1 Dec 2022

Using DECT-derived metrics to definitively diagnose incidental adrenal adenomas

According to an open-access Editor's Choice accepted manuscript published in ARRS' American Journal of Roentgenology, for adrenal lesions evaluated by single-phase dual-energy CT (DECT), fat fraction had higher sensitivity than virtual non-contrast attenuation at both the clinically optimal threshold and at the traditional ≤10 HU threshold.

1 Dec 2022

COVID-19 infection may lead to long-term liver injury

COVID-19 infection is associated with increased liver stiffness, a sign of possible long-term liver injury, according to the results of a new study being presented today at the annual meeting of the Radiological Society of North America.

1 Dec 2022

Harmful gut bacteria co-opt a genetic susceptibility to trigger Crohn’s disease

Changes in a single gene open the door for harmful gut bacteria to set off the inflammation that drives Crohn’s disease, according to a new study led by Weill Cornell Medicine and NewYork-Presbyterian investigators.

1 Dec 2022

Study identifies optimal blood tests for Alzheimer's detection and disease monitoring

A new study have identified which blood tests are best at detecting Alzheimer's disease during the earliest stages, and another blood test that is optimal for detecting relevant treatment effects.

1 Dec 2022

Research shows promising results using neurotechnological approaches to treat youth depression

New research shows promising results using neurotechnological approaches to treat depression in youth. The research, led by Simon Fraser University (SFU) professor Faranak Farzan, is published in the Journal of Affective Disorders Reports.

1 Dec 2022

Discontinuation of opioid therapy for pain may increase overdose risk

Opioid-related overdose is now a leading cause of accidental death in the United States and Canada. A study published December 1st in the open access journal PLOS Medicine by Mary Clare Kennedy at University of British Columbia, Kelowna, Canada, and colleagues suggests discontinuing prescribed opioids was associated with increased overdose risk.

1 Dec 2022

New evidence on the links between immune activation and neuroinflammation and Parkinson's disease

In this special supplement to the Journal of Parkinson's Disease, "The Immune System in Parkinson's Disease," experts highlight the latest research breakthroughs on the links between immune activation and neuroinflammation and Parkinson's disease (PD) and discuss the challenges and novel therapeutic strategies targeting the immune system with the hope of reducing or reversing neurodegeneration.

1 Dec 2022

New, nanotech-based strategy could enable safe, long-term treatment for autoimmune diseases

Scientists at Scripps Research have reported success in initial tests of a new, nanotech-based strategy against autoimmune diseases.

1 Dec 2022

Researchers develop 3D organoid model to advance understanding of gastroesophageal junction cancer

Researchers at Johns Hopkins Medicine say they have created a laboratory-grown three-dimensional "organoid" model that is derived from human tissue and designed to advance understanding about how early stages of cancer develop at the gastroesophageal junction (GEJ) — the point where the digestive system's food tube meets the stomach.

1 Dec 2022

Fibromuscular dysplasia and abdominal aortic aneurysm have a “shared complex genetic architecture”

One disease is more common in people assigned female at birth, while the other is more common in people assigned male at birth.

1 Dec 2022

UTHealth Houston professor wins $3.5 million to study the mechanisms of brain receptors involved in neurological disorders

A five-year, nearly $3.5 million grant to study the mechanisms of brain receptors involved in neurological disorders such as learning disabilities has been awarded to Vasanthi Jayaraman, PhD, of UTHealth Houston by the National Institutes of Health.

1 Dec 2022

HU begins human trial for promising treatment to reverse paralysis and language disorder after stroke

Hiroshima University started the human trial for a promising treatment that offers hope in potentially reversing paralysis and language disorder after moderate to severe stroke using therapeutically superior mesenchymal stem cells (MSCs) derived from the cranial bone.

1 Dec 2022

Scientists discover new potential mechanism for vision loss

Visual cells in the human retina may not simply die in some diseases, but are mechanically transported out of the retina beforehand.

1 Dec 2022

Phase 2 clinical trial of DS-1211 begins for individuals with Pseudoxanthoma Elasticum

A Phase 2 clinical trial has started of DS-1211 in individuals with Pseudoxanthoma Elasticum (PXE), a rare multisystem genetic disease that causes calcium deposits in soft tissue resulting in considerable morbidity.

1 Dec 2022

Impact of COVID-19 on sperm quality

Researchers examined the effect of coronavirus disease 2019 (COVID-19) on sperm quality.

1 Dec 2022

Study compares the performance of two most popular AMD drugs

A pilot, "look-back" study of information about 106 patients with "wet" age-related macular degeneration (AMD) treated at the Wilmer Eye Institute at Johns Hopkins Medicine has revealed that nearly half of patients treated with aflibercept could safely stop eye injection therapy after one year without further vision loss.

30 Nov 2022

Medical Condition News

Study reveals the widespread impact of pandemic on long COVID patients and people with other illnesses

New program lowers the risk of car crashes for teenagers with ADHD

Study implicates gut microbiome health in Parkinson's disease

Very low-calorie and vegan diets improve glycemic control in type 2 diabetes

Using DECT-derived metrics to definitively diagnose incidental adrenal adenomas

COVID-19 infection may lead to long-term liver injury

Harmful gut bacteria co-opt a genetic susceptibility to trigger Crohn’s disease

Study identifies optimal blood tests for Alzheimer's detection and disease monitoring

Research shows promising results using neurotechnological approaches to treat youth depression

Discontinuation of opioid therapy for pain may increase overdose risk

New evidence on the links between immune activation and neuroinflammation and Parkinson's disease

New, nanotech-based strategy could enable safe, long-term treatment for autoimmune diseases

Researchers develop 3D organoid model to advance understanding of gastroesophageal junction cancer

Fibromuscular dysplasia and abdominal aortic aneurysm have a “shared complex genetic architecture”

UTHealth Houston professor wins $3.5 million to study the mechanisms of brain receptors involved in neurological disorders

HU begins human trial for promising treatment to reverse paralysis and language disorder after stroke

Scientists discover new potential mechanism for vision loss

Phase 2 clinical trial of DS-1211 begins for individuals with Pseudoxanthoma Elasticum

Impact of COVID-19 on sperm quality

Study compares the performance of two most popular AMD drugs

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News